Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 489 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Acumen Pharmaceuticals, Inc.
Market Cap
$153.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$152.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$152.16M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-8182.07%
Market Cap
$149.51M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$160.82M
Operating Margin
-8.45%
TTM Avg
-10.66%
3Y Avg
-19.64%
5Y Avg
-13.31%
Market Cap
$146.66M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-4081.44%
5Y Avg
-3115.66%
Market Cap
$162.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-615.66%
Market Cap
$143.81M
Operating Margin
-239.78%
TTM Avg
-210.59%
3Y Avg
-1665.90%
5Y Avg
-1977.59%
Market Cap
$142.49M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | $153.84M | 0.00% | 0.00% | 0.00% | 0.00% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | 0.00% | 0.00% | 0.00% | -8182.07% |
| Codexis, Inc. (CDXS)vs › | $149.51M | -54.46% | -76.53% | -68.82% | -55.26% |
| Inogen, Inc. (INGN)vs › | $160.82M | -8.45% | -10.66% | -19.64% | -13.31% |
| Immuneering Corporation (IMRX)vs › | $146.66M | 0.00% | 0.00% | -4081.44% | -3115.66% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | 0.00% | 0.00% | 0.00% | -615.66% |
| Korsana Biosciences, Inc. (KRSA)vs › | $143.81M | -239.78% | -210.59% | -1665.90% | -1977.59% |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -111.00% | -151.19% | -184.89% | -203.40% |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | -221.72% | -110.86% | -55.43% | -36.95% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | -407.60% |
| 2020-09-30 | -341.10% |
| 2020-06-30 | -1347.68% |
| 2020-03-31 | -905.31% |
